Gilead

Patients

Addressing the HIV epidemic in Eastern Europe and Central As...

Working in partnership will be key, says Alex Kalomparis, vice president, public affairs, international at Gilead Sciences.

Patients

Close up view of a dedicated worker carrying a stack of duck taped brown boxes in factory storage room while wearing sterile cloths and rubber gloves.

Improving access to treatments in challenging markets

The COVID-19 pandemic has highlighted the importance of ensuring a reliable supply of treatments across the globe at pace and speed. Jirair Ratevosian, executive director of global patient

Views & Analysis

How-cell-and-gene-therapies-are-transforming-the-pace-of-deal-making

New Cell & Gene Therapy Collective seeks to boost UK adoptio...

The UK has been a global leader in introducing cell and gene therapies that can potentially transform the lives of patients with debilitating diseases – but there are still many barriers to

News

NICE’s track record in cancer drugs: the impact of the CDF and the role of interim funding

Allogene set to disrupt CAR-T market with pivotal trial of '...

In 2018, the former leadership of team from Kite Pharma founded Allogene, on a mission to outdo the CAR-T cancer cell therapies they had just sold to Gilead for $12 billion with an "off-the

R&D